|
Issues with the DePuy Pinnacle Hip Implant:
What is it all about?
|
In August of 2010, Johnson & Johnson subsidiary, DePuy Orthopedics, issued a recall of its ASR XL Hip Implant,
while its Pinnacle Hip Implant, a similarly designed product in the DePuy Orthopedics line, failed to receive
such a mandate from its manufacturer. Growing concerns about this implant center on its reliance on a defective
metal on metal design, which has a propensity for loosening of the device components, hip dislocation, implant
failure, and blood metal poisoning.
|
|
While the DePuy Pinnacle Hip Implant has yet to be recalled, high failure rates and patients presenting with
metallosis and other serious side effects and symptoms have resulted in numerous lawsuits targeted at DePuy and
its Pinnacle Hip Replacement Product. The number of lawsuits has even prompted speculation that Federal lawsuits
focused on the
|
|
DePuy Pinnacle Hip Implant may be consolidated into a nationwide multidistrict litigation, or MDL.
While such a consolidation has not yet come to fruition, it is not too early to make a determination as to whether
or not you or someone you know might have a potential case against DePuy Orthopedics pertaining to injuries suffered
from its Pinnacle Hip Implant.
If you or someone you know has experienced Hip Implant dislocation, has suffered a Hip Implant Failure,
has tested positive for blood metal poisoning, or has been the victim of some other kind of Hip Implant
related injury, please contact the attorneys at Sullo & Sullo, LLP to tell us about your case. The qualified
and experienced attorneys at Sullo & Sullo, LLP are eager to learn more about your case.
|
|
|
|
|
|
|
|
|
Free Consultation
|
|
Receive an immediate response to your request.
|
|
|
|
|
|
DePuy Hip Recall:
Topics of Interest
|
|
The Recent Articles and Publications
|
|
|
|
February 01, 2012
|
|
Taking Charge: A Blueprint for DePuy Hip Implant Recipients to Follow for Successful Recovery
|
|
While the FDA began receiving complaints regarding the failure of hip replacement devices manufactured by DePuy Orthopedics (a subsidiary of Johnson & Johnson) for some time, there was not a DePuy hip extensive recall on the device until August of 2010. Many feel the recall should have come much sooner and that the company knew there were issues with the implant for a significant period of time before they issued the recall. Many of the patients who have been implanted with a DePuy hip repla
|
|
Full Story
|
|
|
|
|
February 01, 2012
|
|
“Hip” Definitions: A Discussion of Medical Terms Every DePuy Hip Implant Recipient Should Know
|
|
July of 2003 saw the worldwide introduction of the metal-on-metal hip replacement by DePuy, although these devices were not used for hip replacement surgeries in the United States until 2005. Johnson & Johnson, the parent company of DePuy, pushed the approval of the hip implant device through the FDA under an expedited process known as the 510(k). This process allows many medical devices to skip rigorous clinical trials when the manufacturer can show the device is substantially equivalent to
|
|
Full Story
|
|
|
|
|
February 01, 2012
|
|
Johnson & Johnson Takes $3 Billion Dollar Fourth Quarter Charge
|
|
Johnson & Johnson, the parent company of DePuy Orthopedics recently took a fourth quarter charge of over $3 billion dollars related primarily to their voluntary recall artificial hip implants—the DePuy ASR Acetabular System and the ASR Hip Resurfacing System. The recall took place in August of 2010, after the FDA had received incident reports regarding the DePuy metal-on-metal hip implants for over two years. Approximately one in eight patients—and possibly more—will require a hip revision s
|
|
Full Story
|
|
|
|
No article available
|
|
|
|
|
|